Role of genetic polymorphisms in clopidogrel response variability: a systematic review

Role of genetic polymorphisms in clopidogrel response variability: a systematic review

Introduction Clopidogrel is a P2Y12 inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischaemic strokes in patients with significant vascular...

Full description

Bibliographic Details
Main Authors:	José López, An Tran, Justin Mark, Gustavo J Duarte, Mohammed Shaban, Franklin Sosa, Rishabh Mishra, Swati Jain, Asma Khizar, Daniel Karpel, Giancarlo Acosta, Miguel Rodriguez-Guerra
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/10/2/e002436.full

Similar Items

Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases
by: Franklin Sosa, et al.
Published: (2024-03-01)

Resistência ao clopidogrel: prevalência e variáveis associadas Resistance to clopidogrel: prevalence and associate variables
by: Fabrício Braga da Silva, et al.
Published: (2012-12-01)

Resistência ao clopidogrel: prevalência e variáveis associadas Resistance to clopidogrel: prevalence and associate variables
by: Fabrício Braga da Silva, et al.
Published: (2012-01-01)

ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
by: Mugosa Snezana, et al.
Published: (2021-02-01)

Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCI.
by: Kyung Woo Park, et al.
Published: (2013-01-01)

Diuretic resistance and the role of albumin in congestive heart failure
by: Carol Fernandez Hazim, et al.
Published: (2023-12-01)

Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms
by: D F Mesitskaia, et al.
Published: (2014-09-01)

Rare but possible: clopidogrel-induced pancytopenia
by: Pietro Bocchi, et al.
Published: (2023-10-01)

Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese
by: Xiaodong Wang, et al.
Published: (2016-01-01)

The Correlation Between Gene Polymorphism and Clopidogrel Resistance in People of the Hui and Han Nationalities
by: Jing Zhang MD, et al.
Published: (2022-01-01)

The polymorphism of cytochrome P450 CYP2C19 and resistance to clopidogrel.
by: C. Simoglou
Published: (2017-03-01)

CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)

Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
by: Zaril H. Zakaria, et al.
Published: (2018-07-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting
by: Jong-Won Chung, et al.
Published: (2019-01-01)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
by: Lida Chen, et al.
Published: (2022-10-01)

Clopidogrel resistance in cardiovascular disease patients and its association with gene polymorphisms: A pilot study
by: S Parameshwara, et al.
Published: (2021-01-01)

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
by: Mohammed Ahmed Akkaif, et al.
Published: (2021-04-01)

Preparation and In-Vitro Evaluation of Clopidogrel Bisulfate Liquisolid Compact
by: Amina M. Mohammed, et al.
Published: (2018-12-01)

Acute myocardial infarction occurring while on chronic clopidogrel therapy ('clopidogrel failure') is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis.
by: Ehud Regev, et al.
Published: (2018-01-01)

The correlation between CYP2C19 Polymorphisms and recurrent risk in Patients with Ischemic Stroke treated with Clopidogrel in Kurdistan region-Iraq
by: Hind Salim Jardaq, et al.
Published: (2022-12-01)

Clopidogrel and percutaneous coronary interventions.
by: Choudhury, R
Published: (2003)

Clopidogrel and percutaneous coronary interventions.
by: Bridges, J
Published: (2003)

THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Clopidogrel Resistance: Current Issues
by: NS Neki
Published: (2016-05-01)

Clopidogrel resistance and genetic factors
by: Alev Arat Özkan
Published: (2013-07-01)

Clopidogrel Resistance in Stroke Cases
by: Nihan Çarçak, et al.
Published: (2019-11-01)

Clopidogrel-Induced Recurrent Polyarthritis
by: Sahil Agrawal MD, et al.
Published: (2013-08-01)

Diabetes mellitus and clopidogrel “resistance”
by: Laura Massarelli, et al.
Published: (2015-10-01)

Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention
by: Hasan, Md. Shariful, et al.
Published: (2013)

Cytochrome P-450 CYP2C19 genetic polymorphism and its relation with clopidogrel resistance
by: Usman Nawaz, et al.
Published: (2023-11-01)

The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
by: Jia Su, et al.
Published: (2017-01-01)

Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
by: Kreutz RP, et al.
Published: (2013-12-01)

A genetic polymorphism in P2RY 1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy
by: Yu Ueda, et al.
Published: (2021-06-01)

Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel
by: Xingyang Yi, et al.
Published: (2020-04-01)

The good genotype for clopidogrel metabolism is associated with decreased blood viscosity in clopidogrel-treated ischemic stroke patients
by: Joong Hyun Park, et al.
Published: (2020-12-01)

La era de la farmacogenómica: el ejemplo del clopidogrel Farmacogenomics Era: The Clopidogrel Example
by: Allan Ramos-Esquivel, et al.
Published: (2012-03-01)

Polymorphism in S(+)Clopidogrel-Picrate: Insights from X-ray Diffraction, Vibrational Spectroscopy, Thermal Analysis, and Quantum Chemistry
by: Aleksandar Cvetkovski, et al.
Published: (2023-12-01)

Influence of CYP450 Enzymes and ABCB1 Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
by: Mouhrach I, et al.
Published: (2023-10-01)